About EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
HAL Allergy
2
Idorsia Pharmaceuticals Ltd.
2
ViiV Healthcare
1
Clinical Trials at EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej
During the past decade, EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
2020-06-11
2021-07-13
Completed
727
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej"
#1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej
According to Clinical.Site data, the most researched conditions in "EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej" are
"Allergic Rhinitis" (2 trials), "Allergic Rhinoconjunctivitis" (2 trials), "Dermatitis, Atopic" (2 trials), "Insomnia Disorder" (2 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej" in a lesser frequency.
Clinical Trials Intervention Types at EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej
Most popular intervention types in "EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej" are "Drug" (7 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Abrocitinib 200 mg" (2 trials), "Daridorexant 25 mg" (2 trials), "Daridorexant 50 mg" (2 trials) and "Abrocitinib 100 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej
The vast majority of trials in "EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej" are
8 trials for "All" genders.
Clinical Trials Status at EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej
Currently, there are NaN active trials in "EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".